Show simple item record

dc.contributor.authorWilliams, Peter C
dc.contributor.authorHunter, Robin D
dc.contributor.authorJackson, S M
dc.date.accessioned2011-07-20T13:52:41Z
dc.date.available2011-07-20T13:52:41Z
dc.date.issued1979-04
dc.identifier.citationWhole body electron therapy in mycosis fungoides--a successful translational technique achieved by modification of an established linear accelerator. 1979, 52 (616):302-7 Br J Radiolen
dc.identifier.issn0007-1285
dc.identifier.pmid109157
dc.identifier.doi10.1259/0007-1285-52-616-302
dc.identifier.urihttp://hdl.handle.net/10541/136415
dc.description.abstractA translational technique, adapting an established MEL SL75/10 linear accelerator, which gives a satisfactory physical and clinical 3 MeV whole-body electron treatment in mycosis fungoides is described. Tolerance of the patients proved excellent and 16 out of 21 achieved satisfactory remission of the disease. In spite of delivering significant skin doses it was possible to re-treat two relapsing patients without complications and with clinical success.
dc.language.isoenen
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshElectrons
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshMycosis Fungoides
dc.subject.meshParticle Accelerators
dc.subject.meshRadiotherapy Dosage
dc.subject.meshRadiotherapy, High-Energy
dc.subject.meshSkin Neoplasms
dc.titleWhole body electron therapy in mycosis fungoides--a successful translational technique achieved by modification of an established linear accelerator.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital and Holt Radium Institute, Manchesteren
dc.identifier.journalThe British Journal of Radiologyen
html.description.abstractA translational technique, adapting an established MEL SL75/10 linear accelerator, which gives a satisfactory physical and clinical 3 MeV whole-body electron treatment in mycosis fungoides is described. Tolerance of the patients proved excellent and 16 out of 21 achieved satisfactory remission of the disease. In spite of delivering significant skin doses it was possible to re-treat two relapsing patients without complications and with clinical success.


This item appears in the following Collection(s)

Show simple item record